Status:
COMPLETED
Prospective Analysis of the Feasibility of the PASCAL Spacer Technology for Transcatheter Mitral Valve Repair in an All-comers Cohort
Lead Sponsor:
University Hospital, Essen
Conditions:
Mitral Regurgitation
Eligibility:
All Genders
18+ years
Brief Summary
To identify changes on mitral valve morphology and functionality by the application of the PascalTM in MR.
Detailed Description
Transcatheter mitral valve repair (TMVR) in mitral regurgitation (MR) is increasingly applied in patients on high surgical risk. Interventional mitral valve repair can be applied is routinely applied ...
Eligibility Criteria
Inclusion
- • All patients who undergo TVMR for MR (age \>18yrs) at the PI´s site
Exclusion
- \<18yry
- Subject does not provide full consent
Key Trial Info
Start Date :
July 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04473092
Start Date
July 20 2020
End Date
September 30 2022
Last Update
November 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Essen, Westgerman Heart and Vascular Center, Department of Cardiology and Vascular Medicine
Essen, North Rhine-Westphalia, Germany, 45147